Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Oliaro

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
The New England Journal of Medicine|February 12, 2025
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory MyelomaSimon J Harrison, Cyrille Touzeau, Nicolas Kint, et al.
Nature|April 10, 2024
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacyJack D Chan, Christina M Scheffler, Isabelle Munoz, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
The New England Journal of Medicine|February 12, 2025
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory MyelomaSimon J Harrison, Cyrille Touzeau, Nicolas Kint, et al.
Nature|April 10, 2024
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacyJack D Chan, Christina M Scheffler, Isabelle Munoz, et al.
Pageof 6